Creative Medical Technology Holdings (CELZ) Convertible Debt (2017 - 2021)
Creative Medical Technology Holdings (CELZ) posted quarterly Convertible Debt of $498800.0 for Q4 2021, down 39.99% year-over-year from $831140.0 in Q4 2020, and little changed quarter-over-quarter from $498800.0 in Q3 2021.
Creative Medical Technology Holdings (CELZ) Convertible Debt (2017 - 2021) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Convertible Debt for 3 consecutive years, with $498800.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Convertible Debt fell 39.99% year-over-year to $498800.0; the TTM figure through Dec 2021 stood at $498800.0 (down 39.99% YoY), while the FY2021 annual figure was $498800.0, down 39.99% from the prior year.
- Convertible Debt held at $498800.0 in Q4 2021 per CELZ's latest filing, from $498800.0 in the prior quarter.
- Across five years, Convertible Debt topped out at $831140.0 in Q4 2020 and bottomed at $915.0 in Q4 2017.
- Historically, Convertible Debt has averaged $301617.6 across 3 years, with a median of $238025.0 in 2020.
- On a YoY basis, Convertible Debt climbed as much as 6.39% in 2021 and fell as far as 50.72% in 2021.
- Creative Medical Technology Holdings' Convertible Debt stood at $915.0 in 2017, then jumped by 90734.97% to $831140.0 in 2020, then plunged by 39.99% to $498800.0 in 2021.
- Business Quant data shows CELZ's Convertible Debt at $498800.0 in Q4 2021, $498800.0 in Q3 2021, and $157150.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Creative Medical Technology Holdings | 1.83 Mn | 1.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 498,800.00 |
| Sep 30, 2021 | 498,800.00 |
| Jun 30, 2021 | 157,150.00 |
| Mar 31, 2021 | 157,150.00 |
| Dec 31, 2020 | 831,140.00 |
| Sep 30, 2020 | 532,850.00 |
| Jun 30, 2020 | 318,900.00 |
| Dec 31, 2017 | 915.00 |
| Sep 30, 2017 | 14,402.00 |
| Jun 30, 2017 | 6,069.00 |